Mechanistic and functional differentiation of tapentadol and tramadol

@article{Raffa2012MechanisticAF,
  title={Mechanistic and functional differentiation of tapentadol and tramadol},
  author={R. Raffa and H. Buschmann and T. Christoph and G. Eichenbaum and W. Englberger and C. Flores and T. Hertrampf and B. K{\"o}gel and K. Schiene and W. Strassburger and R. Terlinden and T. M. Tzschentke},
  journal={Expert Opinion on Pharmacotherapy},
  year={2012},
  volume={13},
  pages={1437 - 1449}
}
  • R. Raffa, H. Buschmann, +9 authors T. M. Tzschentke
  • Published 2012
  • Medicine
  • Expert Opinion on Pharmacotherapy
    • Introduction: Many opioid analgesics share common structural elements; however, minor differences in structure can result in major differences in pharmacological activity, pharmacokinetic profile, and clinical efficacy and tolerability. Areas covered: This review compares and contrasts the chemistry, pharmacodynamics, pharmacokinetics, and CNS ‘functional activity' of tapentadol and tramadol, responsible for their individual clinical utilities. Expert opinion: The distinct properties of… CONTINUE READING
    View on Taylor & Francis
    ncbi.nlm.nih.gov
    117 Citations
    Highly Influencial Citations
    8
    Background Citations
    42
    Methods Citations
    1
    117 Citations
    Citation Type

    Citation Type

    Comparative pharmacology and toxicology of tramadol and tapentadol
    • 23
    Comparative metabolism of tramadol and tapentadol: a toxicological perspective
    • 31
    • Highly Influenced
    Is tapentadol different from classical opioids? A review of the evidence
    • 43
    • PDF
    Tapentadol: an analgesic that differs from classic opioids due to its noradrenergic mechanism of action.
    • 5
    The switch from buprenorphine to tapentadol: is it worth?
    • A. Miclescu
    • Medicine
    • Romanian journal of anaesthesia and intensive care
    • 2016
    • 1
    • PDF
    The Mu-Opioid Receptor Agonist/Noradrenaline Reuptake Inhibition (MOR–NRI) Concept in Analgesia: The Case of Tapentadol
    • 66
    Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’
    • 28
    • PDF
    The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review.
    • 9
    PharmGKB summary: tramadol pathway.
    • 48
    • PDF
    Miotic and subject-rated effects of therapeutic doses of tapentadol, tramadol, and hydromorphone in occasional opioid users
    • 15
    • Highly Influenced

    References

    SHOWING 1-10 OF 78 REFERENCES
    In vitro and in vivo characterization of tapentadol metabolites.
    • 61
    Tramadol--the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of pain.
    • U. Klotz
    • Medicine
    • Arzneimittel-Forschung
    • 2003
    • 93
    Tapentadol and its two mechanisms of action: Is there a new pharmacological class of centrally‐acting analgesics on the horizon?
    • H. Kress
    • Medicine
    • European journal of pain
    • 2010
    • 110
    • Highly Influential
    [Pharmacology of tramadol].
    • 166
    Synergistic Interaction between the Two Mechanisms of Action of Tapentadol in Analgesia
    • 103
    Role of active metabolites in the use of opioids
    • 95
    • PDF
    Affinity, potency and efficacy of tramadol and its metabolites at the cloned human µ-opioid receptor
    • 243
    Tramadol, M1 metabolite and enantiomer affinities for cloned human opioid receptors expressed in transfected HN9.10 neuroblastoma cells.
    • 71
    Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain.
    • R. Barkin
    • Medicine
    • American journal of therapeutics
    • 2008
    • 52
    Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.
    • 405